Cross-species cell acceptance in embryos, nuclear transfer into malaria progeny and an alkaloid pathway moved into tobacco expose critical handoffs in biological production.
Science··Morning
The immune threshold for accepting a foreign cell
The Cell study from teams at the Institute of Science Tokyo and Stanford explains the persistence of donor cells from another species not only through developmental compatibility, but also through early immune recognition. In a foreign environment, phosphatidylserine that normally remains on the inner face of the donor-cell membrane becomes exposed. The Axl receptor on macrophages in the host embryo reads that signal and engulfs a living donor cell; the researchers call the process xenophagocytosis. They tested three groups of interventions. The first depleted host macrophages or disabled Axl; the other two made donor cells express CD47 or increased ATP11C activity so phosphatidylserine stayed inside the membrane. These interventions raised the success rate of forming a rat pancreas in a mouse embryo. In experiments that placed human cells in mice, the reported advance was not organ formation but better cell survival after host macrophages were reduced. The news therefore concerns a recognition threshold overcome in rodents and a more limited human-cell survival result, not a functioning human organ grown for transplantation.[1]
The physical handoff that guides a nucleus into progeny
Two studies announced together on Plasmodium falciparum show how one cell solves two different handoff problems while producing many progeny. The EMBO Journal study identifies two proteins that link each newly copied nucleus to the tip of a budding daughter parasite. When one component of the tether is removed, genomes are still copied but viable progeny do not form; production of sporozoites, the mosquito stage transmitted to people, is almost completely abolished. The companion study in Nature Communications reports that nuclei sharing one cytoplasm compete for a limited supply of replication proteins. When one nucleus receives that resource, the others wait, so DNA replication proceeds in staggered rather than synchronized rounds. Live-cell imaging, mathematical modelling and experimental validation together indicate that this apparently irregular timing can keep the protein resource in use with little idle time and can outperform fully synchronized replication. One study makes visible the physical link that directs a nucleus into the correct daughter; the other follows the allocation of a replication resource among nuclei over time. Neither report presents a drug candidate or clinical data.[2]
A plant pathway was made to run in another plant
The diterpenoid-alkaloid pathway in wolfsbane and larkspur provides a third handoff: a production chain that can be moved between plant species. Researchers at Michigan State University and the Czech Academy of Sciences tracked genes active together in different tissues and identified six entry enzymes for producing atisinium. When that genetic blueprint was transferred into tobacco plants, the enzymes worked together and produced atisinium; the team also found an unexpected route by which nitrogen enters the structure. The result opens a way to study a family of compounds that has resisted laboratory synthesis because of its structural complexity, using a host outside the source plant. The report gives no result on yield, scale-up or drug development. Across the three developments, researchers separate one transfer step instead of treating an organism as a sealed box: a donor cell passes host recognition, a nucleus is linked to a daughter structure, and an enzyme sequence runs in a new host. Making those handoffs visible makes them available to intervention, while the present results remain at the level of mechanism and method before organs, medicines or industrial production.[3], [1], [2]
Related columns
For more information on this topic, you can read the related columns.
